SEC Form 4 · accession 0001567619-18-008475
BLONDER TONGUE LABORATORIES INC · BDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen K Necessary
Director
Period of report
Dec 19, 2018
Accepted (ET)
Dec 21, 2018 · 9:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000683
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 | Dec 19, 2018 | A | 6,379 | $1.215 | A | 10,379 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to the company's Amended and Restated Director Stock Purchase Plan, the reporting person has elected to receive a fully vested stock award for shares of the company's common stock in lieu of cash payment of director fees otherwise payable to the reporting person. The number of shares of common stock awarded represents the quotient of (i) the director fees payable to the reporting person divided by (ii) $1.2125, representing the average of the high and low trading prices reported on the NYSE American on December 19, 2018.